Streetbeat News

Products Services

BABA

WMT

Alibaba's grocery arm, Freshippo, is targeting a Hong Kong IPO by mid-November, marking the first spin-off listing for the company. Freshippo offers a Walmart Sam's Club-like experience and generated $8.4 billion in revenue in 2022.

Portfolio Pulse from Anusuya Lahiri

June 27, 2023 | 12:08 pm

RVYL

V

RYVYL Inc. announced a strategic partnership between its subsidiary RYVYL EU and Visa to enable Visa Direct for fast and secure account-to-account transfers. This collaboration aims to revolutionize fund transfers, providing fast, convenient, and secure transactions.

Portfolio Pulse from Happy Mohamed

June 27, 2023 | 12:07 pm

PRTK

Paratek Pharmaceuticals announced that the European Medicines Agency Committee for Orphan Medicinal Products has recommended a positive opinion for orphan medicinal product designation for Nuzyra (Omadacycline) for nontuberculous mycobacterial lung disease.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 12:06 pm

RGLS

Regulus Therapeutics has dosed the first patient in the second cohort of the Phase 1b MAD study of RGLS8429 for the treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD). The trial is progressing well, with topline data from the first cohort expected around the end of Q3.

Portfolio Pulse from Happy Mohamed

June 27, 2023 | 12:03 pm

BLK

Bitcoin reaches $30,000 level, prompting reactivation of two Satoshi-era wallets containing 100 BTC worth over $3 million. This coincides with BlackRock filing for a Bitcoin ETF, which could provide more accessible investment opportunities for institutional and individual investors.

Portfolio Pulse from Mehab Qureshi

June 27, 2023 | 11:59 am

ACET

Adicet Bio Inc (NASDAQ:ACET) reported safety and efficacy data from its Phase 1 study of ADI-001 for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma (NHL). The trial showed a 71% overall response rate and 63% complete response rate across all dose levels. JMP Securities downgraded Adicet Bio to Market Perform from Market Outperform rating. The company plans to progress the ADI-001 program into a potential pivotal Phase 2 study in post-CAR T large B-cell lymphoma in the first half of 2024.

Portfolio Pulse from Vandana Singh

June 27, 2023 | 11:49 am

AAPL

An Ontario man credits Apple Watch's Fall Detection feature for saving his life after he fell off a ladder and was unable to call for help. Apple Inc.'s (NASDAQ:AAPL) smartwatches have been praised for their health monitoring and detection features, which have saved lives on multiple occasions.

Portfolio Pulse from Rounak Jain

June 27, 2023 | 11:48 am

J

Jacobs (NYSE:J) has signed an Engineering Partnering Agreement with Fortescue Future Industries to support its global ammonia, green hydrogen, and renewable energy project targets.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 11:48 am

EWTX

Edgewise Therapeutics has released positive 12-month topline results from the ARCH study, evaluating EDG-5506 in adults with Becker Muscular Dystrophy (BMD). The drug was well-tolerated, with significant decreases in key biomarkers of muscle damage. A pivotal cohort, GRAND CANYON, has been added to the CANYON study, with enrollment expected in Q3 2023.

Portfolio Pulse from Vandana Singh

June 27, 2023 | 11:43 am

APCX

AppTech Payments Corp (NASDAQ:APCX) has granted a patent license to PayToMe.co, a Silicon Valley-based fintech company focused on revolutionizing digital financial services.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 11:38 am